HPR231 Equity Analysis in Accessibility of Chinese National Reimbursement Drug List
Abstract
Authors
Y Liu X Lin L Zhu B Zhu J Hu F Li
Y Liu X Lin L Zhu B Zhu J Hu F Li
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now